AlzeCure Pharma AB insider transactionsStockholm
LEI 5493001EJLEBXFY6I446 · XSTO · SE · Business ID 559094-8302
Get alerts for AlzeCure Pharma AB
Recent insider sentiment
No open-market buying or selling — last 90 days
Share-award batches are excluded from this read — they’re compensation, not conviction.
0
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
0
Active insiders (90d)
Transactions
| Date | Person | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 02.07.2026 | Martin Jönsson — CEO | New shares (subscription) | 184,914 | SEK 1.31 | SEK 242,237.34 | ↗ |
| 01.07.2026 | Pontus Forsell — Management | New shares (subscription) | 194,940 | SEK 1.31 | SEK 255,371.40 | ↗ |
| 30.06.2026 | Thomas Pollare — Board member | New shares (subscription) | 240,625 | SEK 1.31 | SEK 315,218.75 | ↗ |
| 30.06.2026 | Oncolution AB — Board member | New shares (subscription) | 327,406 | SEK 1.31 | SEK 428,901.86 | ↗ |
| 26.06.2026 | Johan Sandin — Management | New shares (subscription) | 177,275 | SEK 1.31 | SEK 232,230.25 | ↗ |
| 25.08.2025 | Martin Jönsson — CEO | Bought — open marketAcquisition | 8,067 | SEK 2.19 | SEK 17,666.73 | ↗ |
| 30.07.2025 | Märta Segerdahl Storck — Management | New shares (subscription) | 55,624 | SEK 2.20 | SEK 122,372.80 | ↗ |
| 29.07.2025 | Martin Jönsson — CEO | New shares (subscription) | 23,759 | SEK 2.20 | SEK 52,269.80 | ↗ |
| 28.07.2025 | Johan Sandin — Management | New shares (subscription) | 4,545 | SEK 2.20 | SEK 9,999.00 | ↗ |
| 25.07.2025 | Martin Jönsson — CEO | New shares (subscription) | 178,549 | SEK 2.20 | SEK 392,807.80 | ↗ |
| 24.07.2025 | Jan Lundberg — Board member | New shares (subscription) | 150,000 | SEK 2.20 | SEK 330,000.00 | ↗ |
| 23.07.2025 | Pontus Forsell — Management | New shares (subscription) | 22,727 | SEK 2.20 | SEK 49,999.40 | ↗ |
| 23.07.2025 | Thomas Pollare — Board member | New shares (subscription) | 568,030 | SEK 2.20 | SEK 1,249,666.00 | ↗ |
Active insiders (90d)
No activity in the last 90 days.